Methods for Stabilization in Opioid Dependence
common.study.values.description
“Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol”
The study will enroll 30 opioid-dependent participants into an open-label pilot outpatient study of methods to facilitate induction and stabilization onto XR-NTX. There will be three different methods of XR-NTX induction using increasing doses of oral naltrexone and buprenophine.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Buprenorphine
Buprenorphine will be administered daily
Drug - Naltrexone
On study day 2, participants will receive increasing doses of oral naltrexone prior to administration of XR-NTX
Drug - Vivitrol
Participants will receive one 380 i.m. injection on Study day 5 or 10, and another injection 4 weeks later.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
common.study.values.clinical-trial-id
NCT03113409
participant.views.study.view.id
DdwqMa
